MYO1F and hyperlipidemia: As indicated above, the result of stepwise MLR analysis showed that the combination of clinical risk factors with the four genes with a lower AIC value indicated an association between NCF2, MYO1F, S1PR4, and FCN1 expression levels in PBMCs and male sex, and hyperlipidemia (Table 3).